Anti-TVP23A monoclonal antibody
Pre-made anti-TVP23A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to TVP23A/TVP23A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP2211-Ab-1/ GM-Tg-hg-IP2211-Ab-2 | Anti-Human TVP23A monoclonal antibody | Human |
GM-Tg-rg-IP2211-Ab-1/ GM-Tg-rg-IP2211-Ab-2 | Anti-Rat TVP23A monoclonal antibody | Rat |
GM-Tg-mg-IP2211-Ab-1/ GM-Tg-mg-IP2211-Ab-2 | Anti-Mouse TVP23A monoclonal antibody | Mouse |
GM-Tg-cynog-IP2211-Ab-1/ GM-Tg-cynog-IP2211-Ab-2 | Anti-Cynomolgus/ Rhesus macaque TVP23A monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP2211-Ab-1/ GM-Tg-felg-IP2211-Ab-2 | Anti-Feline TVP23A monoclonal antibody | Feline |
GM-Tg-cang-IP2211-Ab-1/ GM-Tg-cang-IP2211-Ab-2 | Anti-Canine TVP23A monoclonal antibody | Canine |
GM-Tg-bovg-IP2211-Ab-1/ GM-Tg-bovg-IP2211-Ab-2 | Anti-Bovine TVP23A monoclonal antibody | Bovine |
GM-Tg-equg-IP2211-Ab-1/ GM-Tg-equg-IP2211-Ab-2 | Anti-Equine TVP23A monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP2211-Ab-1/ GM-Tg-hg-IP2211-Ab-2; GM-Tg-rg-IP2211-Ab-1/ GM-Tg-rg-IP2211-Ab-2; GM-Tg-mg-IP2211-Ab-1/ GM-Tg-mg-IP2211-Ab-2; GM-Tg-cynog-IP2211-Ab-1/ GM-Tg-cynog-IP2211-Ab-2; GM-Tg-felg-IP2211-Ab-1/ GM-Tg-felg-IP2211-Ab-2; GM-Tg-cang-IP2211-Ab-1/ GM-Tg-cang-IP2211-Ab-2; GM-Tg-bovg-IP2211-Ab-1/ GM-Tg-bovg-IP2211-Ab-2; GM-Tg-equg-IP2211-Ab-1/ GM-Tg-equg-IP2211-Ab-2 |
Products Name | Anti-TVP23A monoclonal antibody |
Format | mab |
Target Name | TVP23A |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-TVP23A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP2211-Ag-1 | Recombinant multi-species TV23A/ TVP23A/ FAM18A protein |
Target information
Target ID | GM-IP2211 |
Target Name | TVP23A |
Gene ID | 780776,383103,360467,710574,490009,101084846,100139027,100056589 |
Gene Symbol and Synonyms | FAM18A,RGD1566405,TVP23A,YDR084C |
Uniprot Accession | A6NH52 |
Uniprot Entry Name | TV23A_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000166676 |
Target Classification | N/A |
The target: TVP23A, gene name: TVP23A, also named as FAM18A, YDR084C. This gene encodes a membrane protein associated with the Golgi apparatus, which plays a crucial role in intracellular vesicular transport. The encoded protein is likely associated with the late (trans) Golgi compartments, which are involved in the delivery of secretory and membrane proteins to the endosome, lysosome or the plasma membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.